美股異動 | 慧榮科技(SIMI.US)盤前大漲超11% 消息稱其正考慮出售自家公司的可能性
格隆匯4月25日丨NAND閃存控制芯片大廠慧榮科技(SIMO.US)盤前大漲超11%,報85.6美元。據彭博慧榮科技正在考慮出售自家公司的可能性,此前,市場上已傳出有追求方釋出收購意願的消息。引述消息人士的説法,SMI 與一家以上的潛在收購方進行協商,正與顧問業者合作。消息人士要求匿名,原因是慧榮的相關研議都是私下的,目前尚未做出最終決定,而且也可能選擇不出售公司。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.